Discussion of: “Pre-surgical chemotherapy for breast cancer may be associated with improved outcomes”

- Response to neoadjuvant chemotherapy for breast cancer varies by tumor subtype.
- Tumor subtype and surgical treatment plan should drive decision making.
- Sentinel lymph node biopsy after neoadjuvant chemotherapy can reduce morbidity.